Pfizer CEO Albert Bourla tests COVID-19 positive with mild symptoms
Pfizer Inc (NYSE: PFE) Chief Executive Albert Bourla on Monday said he tested positive for COVID-19 and is receiving Paxlovid, the oral antiviral treatment made by his company
Pfizer
Inc (NYSE: PFE) Chief Executive Albert Bourla on Monday said he tested positive for COVID-19 and is receiving Paxlovid, the oral antiviral
treatment made by his company.
Bourla
said he’s feeling well although experiencing very mild symptoms. He has
received four doses of the COVID-19 vaccine, also made by Pfizer in
collaboration with BioNTech SE.
The
CEO is one of many people who have contracted coronavirus despite
receiving full vaccination and booster doses. The mutating coronavirus
has continually found ways to at least partially evade immunity induced
by shots and previous infections, although usually causing milder cases.
Bourla said he is “isolating in place as well as following all public health precautions.”
Picture Credit: CNBC
ALSO READ:
